-
Blood Cancers Today
Oncology / HematologyJoin us for the 2nd Annual HemOnc Pulse Live Meeting in Austin - 10 day(s) agoDear readers, We would like to invite you to the second annual HemOnc Pulse Live! event, happening May 2-3, 2025, in Austin, Texas. The event,…
Blood Cancers Today
Oncology / HematologyBlood Cancers Today is a property that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings.
-
Blood Cancers Today
Oncology / HematologyFateeha Furqan, MD, Discusses Pirtobrutinib Plus CAR-T - 11 month(s) agoDear readers, The summer conference season is upon us here at Blood Cancers Today. First, we start with updates from the American Society of Clinical…
-
Blood Cancers Today
Oncology / HematologyFateeha Furqan, MD, Discusses Pirtobrutinib Plus CAR-T - 11 month(s) agoDear readers, The summer conference season is upon us.
-
Blood Cancers Today
Oncology / HematologyDear readers, This month, we hosted our first live event of “The HemOnc Pulse” in Chicago with some of the biggest names in hematology and…
-
Blood Cancers Today
Oncology / HematologyDear readers, It has been a busy spring at Blood Cancers Today, with many exciting updates in the world of hematologic oncology. In this newsletter edition,…
-
Blood Cancers Today
Oncology / HematologyDr. Banerjee on the Importance of Myeloma Awareness Month - 1 year(s) agoDear readers, March is Myeloma Awareness Month, and in this newsletter, Rahul Banerjee, MD, FACP, of the Fred Hutchinson Cancer Center, explains why raising awareness on this…
-
Blood Cancers Today
Oncology / HematologyDear reader, The hematology-oncology social community is abuzz this week as the US Food and Drug Administration (FDA) approved a reduced dose of teclistamab 1.5…
-
Blood Cancers Today
Oncology / HematologyBCT Site - 1 year(s) ago
-
Blood Cancers Today
Oncology / HematologyDear reader, This week on Blood Cancers Today, Dr. Shune of the University of Kansas Hospital discusses ide-cel in relapsed or refractory multiple myeloma, Dr.…